Rhabdomyosarcoma in infants and children: factors affecting long-term survival.
D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004357:Drug Synergism; D005121:Extremities; D005260:Female; D006258:Head and Neck Neoplasms; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009918:Orbital Neoplasms; D010386:Pelvic Neoplasms; D011379:Prognosis; D012208:Rhabdomyosarcoma / Q000188:drug therapy / Q000401:mortality* / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D012737:Sex Factors; D014750:Vincristine / Q000627:therapeutic use
D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide